News

@Pharmacy_Times
pharmacytimes. com > view > ada-2026-semaglutide-add-on-reduces-glycemic-burden-cardiometabolic-risk-in-older-adults-with-t2d

ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2 D

3+ week, 5+ day ago  (365+ words) Adding semaglutide to existing regimens in older adults with inadequately controlled T2 D significantly reduced Hb A1c, fasting blood glucose, body weight, and blood pressure. Polypharmacy, potentially inappropriate medications, and clinically relevant drug-drug interactions have been associated with lower quality-of-life outcomes in…...

Symbols: lloy.l,shel.l,btc-usd,0gqu.l,cinh.l,icon.l